In 20 days, Pequeno Príncipe Hospital performs seven kidney transplants
The year 2022 marked the resumption of solid organ and bone marrow transplants in Brazil, which reached the same levels as in 2019, before the COVID-19 pandemic. In pediatrics, 583 procedures were performed. At Pequeno Príncipe Hospital, the high point was the kidney transplants. Until the month of November, the number was below the average of previous years, with only eight procedures performed. However, as of December 13, several donations emerged and, in a period of just over 20 days (until January 9, 2023), the institution performed seven transplants.
“For a transplant to be carried out, great logistics are needed for the capture and transport of the organ and a whole structure with surgeons, anesthesiologists, nurses, ICUs – in short – a large structure is demanded. This number shows how prepared the Pequeno Príncipe is to handle highly complex cases,” says nephrologist Mariana Cunha. The patient Matheus Tavares Silva Cardoso (photo above), 3 years old, was one of the children transplanted during this period.
This is the subject of the main article of the second edition of Pequeno Príncipe News in 2023, that also presents how some procedures performed at the Hospital are represented in the state of Paraná and in Brazil. In its turn, the second article of this newsletter is about the achievement of the 2022 Climate Challenge Award, in the Climate Resilience category. The recognition considers the performance and contributions arising from the engagement and activities developed during the year 2022 in favor of the climate. The global award had the participation of 15 countries, with 50 awarded organizations – seven of which are Brazilian.
At last, the third article is about the largest research in Brazil in telepediatrics, that is coordinated by the Pequeno Príncipe. In 2020, the Hospital brought to Brazil the Israeli technology TytoCare – a small portable device in which the physician can check patient signals from a distance. The technology was already used in adults, and upon its advent in Brazil, it was necessary to scientifically verify the effectiveness of the device in the care of children and adolescents. The conclusion of the research project was that the TytoCare is a safe tool for the healthcare of this public. The study was published in the JAMA Network Open, a leading medical journal edited by the American Medical Association.